Localized rest and stress human cardiac creatine kinase reaction kinetics at 3 T.


Journal

NMR in biomedicine
ISSN: 1099-1492
Titre abrégé: NMR Biomed
Pays: England
ID NLM: 8915233

Informations de publication

Date de publication:
06 2019
Historique:
received: 03 12 2018
revised: 24 01 2019
accepted: 28 01 2019
pubmed: 29 3 2019
medline: 18 12 2019
entrez: 29 3 2019
Statut: ppublish

Résumé

Changes in the kinetics of the creatine kinase (CK) shuttle are sensitive markers of cardiac energetics but are typically measured at rest and in the prone position. This study aims to measure CK kinetics during pharmacological stress at 3 T, with measurement in the supine position. A shorter "stressed saturation transfer" (StreST) extension to the triple repetition time saturation transfer (TRiST) method is proposed. We assess scanning in a supine position and validate the MR measurement against biopsy assay of CK activity. We report normal ranges of stress CK forward rate (k

Identifiants

pubmed: 30920054
doi: 10.1002/nbm.4085
pmc: PMC6542687
mid: EMS82330
doi:

Substances chimiques

Creatine Kinase EC 2.7.3.2

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e4085

Subventions

Organisme : Wellcome Trust
ID : 098436
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/15/80/31803
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/18/12/34040
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/14/54/30946
Pays : United Kingdom
Organisme : BHF Centre of Research Excellence, Oxford
Pays : International
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/13/8/30266
Pays : United Kingdom
Organisme : Wellcome Trust and Royal Society
ID : 098436/Z/12/Z
Pays : International

Informations de copyright

© 2019 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd.

Références

Magn Reson Med. 2002 May;47(5):850-63
pubmed: 11979563
J Lab Clin Med. 1967 Apr;69(4):696-705
pubmed: 4381359
Magn Reson Med. 2017 Jul;78(1):20-32
pubmed: 27579566
NMR Biomed. 2015 Feb;28(2):188-99
pubmed: 25483778
Circulation. 2015 Jan 27;131(4):e29-322
pubmed: 25520374
Circulation. 2012 Mar 27;125(12):1511-9
pubmed: 22368152
Circulation. 2010 Apr 20;121(15):1756-67
pubmed: 20404267
J Mol Cell Cardiol. 1996 Apr;28(4):755-65
pubmed: 8732503
Magn Reson Med. 2010 Jun;63(6):1493-501
pubmed: 20512852
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):808-13
pubmed: 15647364
Curr Treat Options Cardiovasc Med. 2017 Nov 9;19(12):93
pubmed: 29119262
NMR Biomed. 2019 Jun;32(6):e4085
pubmed: 30920054
Eur J Radiol. 2013 May;82(5):745-51
pubmed: 22154589
Heart. 2015 Aug;101(15):1182-9
pubmed: 26041770
Magn Reson Med. 2009 Apr;61(4):785-95
pubmed: 19195018
Biochem J. 1955 Sep;61(1):116-22
pubmed: 13260184
J Cardiovasc Magn Reson. 2015 Aug 08;17:70
pubmed: 26253320
J Cardiovasc Magn Reson. 2018 May 24;20(1):33
pubmed: 29792210
NMR Biomed. 2015 Nov;28(11):1455-62
pubmed: 26404723
Magn Reson Med. 2014 Aug;72(2):304-15
pubmed: 24006267
Nucl Med Commun. 2015 Oct;36(10):971-85
pubmed: 26035516
Clin Chem. 1979 Mar;25(3):446-52
pubmed: 45380
J Magn Reson. 2000 Jan;142(1):120-35
pubmed: 10617442
Circulation. 1997 Aug 19;96(4):1313-9
pubmed: 9286964
Magn Reson Med. 2014 Dec;72(6):1509-15
pubmed: 24470429
J Magn Reson. 2001 Feb;148(2):425-35
pubmed: 11237649
NMR Biomed. 2013 Sep;26(9):1142-51
pubmed: 23436474
Sci Rep. 2014 Jun 09;4:5219
pubmed: 24910264
Circulation. 2009 Apr 14;119(14):1918-24
pubmed: 19332463
NMR Biomed. 2014 Jun;27(6):663-71
pubmed: 24706347
Heart. 2004 Dec;90 Suppl 6:vi23-30
pubmed: 15564422
Circulation. 2006 Sep 12;114(11):1151-8
pubmed: 16952984
Future Cardiol. 2016 Jul;12(4):483-96
pubmed: 27322032

Auteurs

William T Clarke (WT)

Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Division of Cardiovascular Medicine RDM, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Wellcome Centre for Integrative Neuroimaging, FMRIB, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Mark A Peterzan (MA)

Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Division of Cardiovascular Medicine RDM, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Jennifer J Rayner (JJ)

Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Division of Cardiovascular Medicine RDM, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Rana A Sayeed (RA)

Department of Cardiothoracic Surgery, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Mario Petrou (M)

Department of Cardiothoracic Surgery, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

George Krasopoulos (G)

Department of Cardiothoracic Surgery, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Hannah A Lake (HA)

Department of Cardiovascular Medicine, University of Oxford, Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford, UK.

Betty Raman (B)

Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Division of Cardiovascular Medicine RDM, University of Oxford, John Radcliffe Hospital, Oxford, UK.

William D Watson (WD)

Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Division of Cardiovascular Medicine RDM, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Pete Cox (P)

Department of Physiology Anatomy, University of Oxford, Parks Road, Sherrington Building, Oxford, UK.

Moritz J Hundertmark (MJ)

Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Division of Cardiovascular Medicine RDM, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Andrew P Apps (AP)

Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Division of Cardiovascular Medicine RDM, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Craig A Lygate (CA)

Department of Cardiovascular Medicine, University of Oxford, Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford, UK.

Stefan Neubauer (S)

Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Division of Cardiovascular Medicine RDM, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Oliver J Rider (OJ)

Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Division of Cardiovascular Medicine RDM, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Christopher T Rodgers (CT)

Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Division of Cardiovascular Medicine RDM, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Wolfson Brain Imaging Centre, University of Cambridge, Box 65, Cambridge Biomedical Campus, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH